CLOMIPHENE CITRATE MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

View by Category
About This Presentation



Read here the market research report on the “Clomiphene Citrate Market” published by CMI team – PowerPoint PPT presentation

Number of Views:5
Date added: 2 November 2020
Slides: 18
Provided by: kunalbhuta
Category: Other


Write a Comment
User Comments (0)
Transcript and Presenter's Notes


  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Clomiphene Citrate Market, by Indication (PCOS,
    Secondary Amenorrhea, Psychogenic Amenorrhea,
    Amenorrhea Galactorrhea Syndrome, and Others), by
    Distribution Channel (Hospital Pharmacies, Retail
    Pharmacies, and Online Pharmacies), and by Region
    (North America, Latin America, Europe, Asia
    Pacific, Middle East, and Africa) - Size, Share,
    Outlook, and Opportunity Analysis, 2020 - 2027

  • Clomiphene citrate is an oral medication that is
    often used to treat certain types of female
    infertility. Infertility is a global health
    issue, as its affects both men and women.
    Infertility in females could be due to increasing
    age, polycystic ovarian syndrome (PCOS), obesity,
    and multiple miscarriages.

  • Clomiphene citrate works by stimulating an
    increase in the amount of hormones that support
    the growth and release of a mature egg
    (ovulation). This medication is not recommended
    for women whose ovaries no longer make eggs
    properly (primary pituitary or ovarian failure).
    Other names of clomiphene citrate are Clomid,
    Clomifene, Chloramifene, and Chloramiphene. It is
    also used for the treatment of polycystic ovary
    syndrome (PCOS), secondary amenorrhea,
    psychogenic amenorrhea, amenorrhea galactorrhea
    syndrome, and others. It is taken as a 50 mg pill
    that is usually taken for five days in a row in
    the beginning of a womans menstrual cycle.

  • Clomiphene Citrate Market - Impact of Coronavirus
    (Covid-19) Pandemic
  • The COVID-19 pandemic has significantly hampered
    demand for clomiphene citrate because the women
    who are under treatment of clomiphene citrate for
    infertility or PCOS, tests positive for COVID-19
    infection, they must suspend the clomiphene
    citrate treatment and other fertility treatment
    alongside, as per the American Society for
    Reproductive Medicine (ASRM). However, according
    to the American Society for Reproductive Medicine
    data of March 2020, there are reports of women
    who have tested positive for COVID-19 delivering
    babies free of the COVID-19 infection. The
    coronavirus is not a fatal infection for a
    pregnant women.
  • The clomiphene citrate market is estimated to be
    valued at US 10.02 million in 2020 and is
    expected to exhibit a CAGR of 5.4 during the
    forecast period (2020-2027).

  • Figure 1 Clomiphene Citrate Market Share ()
    Analysis, By Indication, 2020

  • The increasing rate of infertility is expected to
    drive growth of the clomiphene citrate market
  • Infertility is a health issue that affects both
    men and women, worldwide. Increasing infertility
    rates is expected to propel global demand for
    clomiphene citrate over the forecast period. For
    instance, according to the Centers for Disease
    Control and Prevention (CDC) report of 2018,
    around 6 of women aged 15 to 44 years in the
    U.S. were unable to conceive after one year of
    continuous intercourse. Furthermore, around 12
    of women aged 15 to 44 years in the U.S. had
    difficulty in conceiving or carrying a pregnancy
    till child birth in 2017. Infertility also
    affects men. According to the same source, around
    9 of men aged 25 to 44 years in the U.S.
    reported that they required medical help for
    reproduction in 2017. Clomiphene is used to treat
    infertility in both men and women. The U.S. FDA
    approved clomiphene citrate for women infertility
    in 1960s whereas, its often prescribed off-label
    for treatment of male infertility.

  • Clomiphene Citrate Market Restraints
  • The clomiphene citrate market is expected to be
    negatively affected, owing to clomiphene
    citrates inefficiency in terms of being a less
    effective treatment to achieve pregnancy and live
    child births when compared to other medicines
    such as Letrozole. For instance, in 2014, a team
    of researchers at National Institutes of Healths
    (NIH) Eunice Kennedy Shriver National Institute
    of Child Health and Human Development (NICHD)
    found that women treated with Letrozole showed
    high rate of ovulation and live births than women
    treated with the standard drug, clomiphene
    citrate. Furthermore, as per the same source,
    among women who received Letrozole, 27.5 of them
    eventually had a live birth and among women who
    received clomiphene, only 19.1 of them
    experienced a live child birth. The cumulative
    ovulation rate was higher for Letrozole group,
    with ovulation occurring 61.7 of the time and
    the women in the clomiphene group ovulated 48.3
    of the time.

(No Transcript)
  • Clomiphene Citrate Market Regional Analysis
  • The North America clomiphene citrate market is
    expected to hold a dominant position in the
    global clomiphene citrate market, owing to the
    high prevalence of polycystic ovary syndrome
    (PCOS) in the U.S. For instance, according to the
    Centers for Disease and Disease Control
    Prevention 2019, PCOS is one of the most common
    causes of female infertility, affecting 6 to 12
    (as many as 5 million) women of reproductive age
    in the U.S. Moreover, more than half of the women
    with PCOS develop type 2 diabetes by age 40.

  • Clomiphene Citrate Market Regional Analysis
  • Furthermore, Europe clomiphene citrate market is
    expected to gain traction in the near future,
    owing to various strategies implemented by the
    key players in the region. Key players are
    focused on providing reimbursements to patients
    to make the medicines available at affordable
    prices. For instance, Sanofi S.A. provides
    reimbursement for CLOMID under the Pharmaceutical
    Benefits Scheme (PBS) in Europe and Australia, in
    order to make the medicines available at
    affordable prices for patients. PBS provides
    timely, reliable, and affordable access to
    fertility medications to the people in Europe and
    Australia. The medicine is prescribed for the
    treatment of ovulatory failure in selected
    infertile women who wish to become pregnant.

  • Figure 2 Clomiphene Citrate Market Value (US
    Mn) Y-o-Y Growth (), 2017-2027

  • Clomiphene Citrate Market - Competitive Landscape
  • Key players operating in the clomiphene citrate
    market include Sanofi S.A., Par Pharmaceutical,
    Merck Co. Inc., Teva Pharmaceutical Industries
    Ltd., Cipla Inc., Unichem Laboratories Ltd.,
    Emcure Pharmaceuticals Ltd., Serum Institute of
    India Pvt. Ltd., Incepta Pharmaceuticals Ltd.,
    and Shanghai Trifecta Pharma Co. Ltd.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//